Greenleaf Trust’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-6,558
| Closed | -$1.42M | – | 753 |
|
|
2021
Q1 | $1.42M | Sell |
6,558
-50,446
| -88% | -$9.48M | 0.02% | 152 |
|
|
2020
Q4 | $6.58M | Hold |
57,004
| – | – | 0.09% | 51 |
|
|
2020
Q3 | $5.55M | Hold |
57,004
| – | – | 0.09% | 50 |
|
|
2020
Q2 | $7M | Hold |
57,004
| – | – | 0.12% | 45 |
|
|
2020
Q1 | $4.99M | Hold |
57,004
| – | – | 0.1% | 47 |
|
|
2019
Q4 | $5.96M | Hold |
57,004
| – | – | 0.09% | 52 |
|
|
2019
Q3 | $6.56M | Hold |
57,004
| – | – | 0.1% | 47 |
|
|
2019
Q2 | $9.83M | Sell |
57,004
-2,750
| -5% | -$476K | 0.16% | 36 |
|
|
2019
Q1 | $10.1M | Buy |
59,754
+4,910
| +9% | +$731K | 0.17% | 30 |
|
|
2018
Q4 | $5.34M | Hold |
54,844
| – | – | 0.11% | 48 |
|
|
2018
Q3 | $9.47M | Sell |
54,844
-2,750
| -5% | -$397K | 0.17% | 29 |
|
|
2018
Q2 | $8.04M | Sell |
57,594
-5,350
| -8% | -$760K | 0.15% | 36 |
|
|
2018
Q1 | $7.09M | Sell |
62,944
-2,950
| -4% | -$371K | 0.14% | 41 |
|
|
2017
Q4 | $8.7M | Sell |
65,894
-8,900
| -12% | -$1.05M | 0.18% | 30 |
|
|
2017
Q3 | $7.59M | Sell |
74,794
-4,900
| -6% | -$525K | 0.17% | 33 |
|
|
2017
Q2 | $7.99M | Sell |
79,694
-2,500
| -3% | -$269K | 0.18% | 28 |
|
|
2017
Q1 | $9.94M | Buy |
82,194
+7,508
| +10% | +$921K | 0.24% | 23 |
|
|
2016
Q4 | $8.35M | Buy |
+74,686
| New | +$8.99M | 0.22% | 31 |
|
Other funds holding GWPH
Greenleaf Trust's GWPH Position: Q2 2021 in Review
Greenleaf Trust sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 6,558 shares — an estimated $1.42M sold.
Greenleaf Trust first reported a position in GWPH in Q4 2016 and held it in 18 quarters. The position peaked at $10.1M in Q1 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Greenleaf Trust reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Greenleaf Trust sold 6,558 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.42M.
- Greenleaf Trust first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 18 quarters.
- Greenleaf Trust's GW Pharmaceuticals Plc American Depositary Shares position peaked at $10.1M in Q1 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Greenleaf Trust's 13F filing for Q2 2021, filed 10 Aug 2021.